Villanova di San Daniele del Friuli, Italy-based LimaCorporate announced the appointment of Rodrigo Bianchi to its Advisory Board.
Rodrigo Bianchi Appointed to LimaCorporate Advisory Board

Bianchi comes to LimaCorporate with over 30 years of experience in orthopedic corporations. He is currently a Senior Global Executive in the medical device industry. He holds a master’s degree in Business from Luiss Business School in Rome and a bachelor’s degree in Economics from Rome University.
Bianchi began his career with Procter & Gamble Italy. He later served for 26 years at Johnson & Johnson, including president Worldwide Ethicon and president Worldwide DePuy Mitek. In his most recent position, Bianchi was president of international markets for Smith & Nephew.
Michel Orsinger, chairman of the board, said of Bianchi’s appointment, “I am excited for Rodrigo to join our Board as his deep understanding of our customers’ needs will help guide LimaCorporate to advance patient care through innovative, total solutions including digital applications that will transform our business and industry.”
Company CEO Luigi Ferrari said, “Rodrigo will bring to LimaCorporate and the Advisory Board new and fresh ideas that will certainly impact the growth of our business around the world, specifically in the APAC [Asia-Pacific] and Emerging markets. His broad experience across different segments of orthopedics will also complement the entire Board.”
The company explained some of Bianchi’s responsibilities to OTW, “LimaCorporate is growing in our core, historical markets and entering new territories around the world. Mr. Bianchi’s experience will support LimaCorporate in reaching these new territories, such as China, as well as strengthening our presence in our other APAC markets.”
Furthermore, “Mr. Bianchi’s understanding of a European company and culture combined with his experience of what is necessary to adapt at a local level to penetrate the APAC markets at an even faster rate is unique. His guidance and strong network will support LimaCorporate to expand our market position.”
LimaCorporate is a global medical device company based in Italy. It provides reconstructive and custom-made orthopedic products to surgeons who are addressing quality of life issues. Products include large joint primary implants, large joint revision implants, and complete extremities solutions as well as fixation solutions. It also has a patient-specific prosthesis division called ProMade.
LimaCorporate’s mission is to offer “innovative solutions to assist orthopedic surgeons in restoring the eMOTION of MOTION.” Its vision is “to be the leading company in niche orthopedic markets to improve surgeon and patient experience, offering innovative, tailored solutions.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.